These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 34657922)

  • 1. [Subacute cognitive impairment and urinary retention due to primary central nervous system post-transplant lymphoproliferative disorder: a case report].
    Yokoyama N; Kanbayashi T; Kobayashi S; Ishida T; Sonoo M
    Rinsho Shinkeigaku; 2021 Nov; 61(11):750-755. PubMed ID: 34657922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary Central Nervous System Post-transplant Lymphoproliferative Disorder Misdiagnosed as Glioblastoma: A Case Report.
    Tanaka H; Matsuda R; Nakamura M; Nakagawa I; Nakase H
    Anticancer Res; 2022 Aug; 42(8):3975-3979. PubMed ID: 35896237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxoplasmic Encephalitis Followed by Primary EBV-Associated Post-Transplant Lymphoproliferative Disorder of the Central Nervous System in a Patient Undergoing Allogeneic Hematopoietic Stem Cell Transplant: A Case Report.
    Mayumi A; Yamashita T; Matsuda I; Hikosaka K; Fujino S; Norose K; Kato Y; Hirota S; Nakajima T; Ogawa H; Ikegame K
    Transplant Proc; 2020 Nov; 52(9):2858-2860. PubMed ID: 32873410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Primary central nervous system post-transplant lymphoproliferative disorders].
    Honda M; Koga M; Kanda T
    Brain Nerve; 2014 Aug; 66(8):947-54. PubMed ID: 25082316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequent intrathecal production of antibodies to the viral capsid antigen of Epstein-Barr virus in patients with central nervous system post-transplant lymphoproliferative disorder.
    Otto C; Radbruch H; Wilken D; Lietzow T; Steinhagen K; Grage-Griebenow E; von Brünneck AC; Jarius S; Hofmann J; Pache F; Ruprecht K
    J Neuroimmunol; 2022 Aug; 369():577902. PubMed ID: 35689981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EBV-positive post-transplant lymphoproliferative disorder presenting as primary diffuse large B-cell lymphoma of the central nervous system.
    Xu H; Rewerska J; Aardsma N; Slavin K; Valyi-Nagy T; Ni H
    Folia Neuropathol; 2017; 55(3):221-226. PubMed ID: 28984115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case series of primary central nervous system posttransplantation lymphoproliferative disorder: imaging and clinical characteristics.
    Lake W; Chang JE; Kennedy T; Morgan A; Salamat S; Başkaya MK
    Neurosurgery; 2013 Jun; 72(6):960-70; discussion 970. PubMed ID: 23685504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-transplantation lymphoproliferative disorder in heart and kidney transplant patients: a single-center experience.
    Wasson S; Zafar MN; Best J; Reddy HK
    J Cardiovasc Pharmacol Ther; 2006 Mar; 11(1):77-83. PubMed ID: 16703222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility-weighted imaging and diffusion-weighted imaging findings in central nervous system monomorphic B cell post-transplant lymphoproliferative disorder before and after treatment and comparison with primary B cell central nervous system lymphoma.
    Ginat DT; Purakal A; Pytel P
    J Neurooncol; 2015 Nov; 125(2):297-305. PubMed ID: 26341369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary central nervous system post-transplantation lymphoproliferative disorder: an International Primary Central Nervous System Lymphoma Collaborative Group Report.
    Cavaliere R; Petroni G; Lopes MB; Schiff D;
    Cancer; 2010 Feb; 116(4):863-70. PubMed ID: 20052713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Primary central nervous system post-transplant lymphoproliferative disorder with few specific abnormal findings observed on MRI and in the cerebrospinal fluid].
    Takeuchi Y; Ochiai J; Onoda O; Nishihira M; Uchida K; Yoshida M
    Rinsho Shinkeigaku; 2022 Jan; 62(1):44-48. PubMed ID: 34924473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-transplant primary central nervous system lymphoma after Epstein-Barr virus cerebellitis.
    Valencia-Sanchez C; Steenerson KK; Kelemen K; Orenstein R; Kusne S; Grill MF
    J Neurovirol; 2019 Apr; 25(2):280-283. PubMed ID: 30607891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus-positive lymphoproliferative disorder manifesting as pulmonary disease in a patient with acute myeloid leukemia: a case report.
    Dutta R; Miao SY; Phan P; Fernandez-Pol S; Shiraz P; Ho D; Mannis GN; Zhang TY
    J Med Case Rep; 2021 Mar; 15(1):170. PubMed ID: 33773605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of immunosuppression combined with whole-brain radiotherapy and concurrent systemic rituximab is an effective yet toxic treatment of primary central nervous system post-transplant lymphoproliferative disorder (pCNS-PTLD): 14 cases from the prospective German PTLD registry.
    Zimmermann H; Nitsche M; Pott C; Reinke P; Babel N; Hermann RM; Hauser IA; Hahn D; Ritgen M; Pietschmann C; Klapper W; Anagnostopoulos I; Trappe RU;
    Ann Hematol; 2021 Aug; 100(8):2043-2050. PubMed ID: 33973053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary CNS lymphoproliferative disease, mycophenolate and calcineurin inhibitor usage.
    Crane GM; Powell H; Kostadinov R; Rocafort PT; Rifkin DE; Burger PC; Ambinder RF; Swinnen LJ; Borowitz MJ; Duffield AS
    Oncotarget; 2015 Oct; 6(32):33849-66. PubMed ID: 26460822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary central nervous system posttransplantation lymphoproliferative disorder after heart and lung transplantation.
    Gifford G; Fay K; Jabbour A; Ma DD
    Intern Med J; 2015 May; 45(5):583-6. PubMed ID: 25955465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orbital Epstein-Barr virus-related post-transplant lymphoproliferative disorder in a 13-year-old girl with cord blood transplantation.
    Shigemura T; Maruyama Y; Shigeto S; Nakazawa Y; Kanno H
    Transpl Infect Dis; 2021 Jun; 23(3):e13536. PubMed ID: 33264446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Epstein-Barr virus donor and recipient serostatus on the incidence of post-transplant lymphoproliferative disorder in kidney transplant recipients.
    Sampaio MS; Cho YW; Shah T; Bunnapradist S; Hutchinson IV
    Nephrol Dial Transplant; 2012 Jul; 27(7):2971-9. PubMed ID: 22273720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extremely delayed-onset post-transplant lymphoproliferative disorder in a renal transplant patient.
    Holland E; Altshuler E; Franke AJ
    BMJ Case Rep; 2022 Aug; 15(8):. PubMed ID: 35977750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-transplant lymphoproliferative disorders, Epstein-Barr virus infection, and disease in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.
    Allen UD; Preiksaitis JK;
    Clin Transplant; 2019 Sep; 33(9):e13652. PubMed ID: 31230381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.